<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">JAMA Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">JAMA Psychiatry</journal-id>
<journal-id journal-id-type="pmc">JAMA Psychiatry</journal-id>
<journal-title-group>
<journal-title>JAMA Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">2168-622X</issn>
<issn pub-type="epub">2168-6238</issn>
<publisher>
<publisher-name>American Medical Association</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30698613</article-id>
<article-id pub-id-type="pmc">6495355</article-id>
<article-id pub-id-type="doi">10.1001/jamapsychiatry.2018.4166</article-id>
<article-id pub-id-type="publisher-id">yoi180103</article-id>
<article-categories>
<subj-group specific-use="electronic" subj-group-type="category">
<subject>Research</subject>
</subj-group>
<subj-group specific-use="print" subj-group-type="domain">
<subject>Research</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Original Investigation</subject>
</subj-group>
<subj-group subj-group-type="online-first">
<subject>Online First</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Association of Polygenic Liabilities for Major Depression, Bipolar Disorder, and Schizophrenia With Risk for Depression in the Danish Population</article-title>
<alt-title alt-title-type="headline">Association of Polygenic Liabilities With Risk for Depression in the Danish Population</alt-title>
<alt-title alt-title-type="running-head">Association of Polygenic Liabilities With Risk for Depression in the Danish Population</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Musliner</surname>
<given-names>Katherine L.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="yoi180103aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mortensen</surname>
<given-names>Preben B.</given-names>
</name>
<degrees>DrMedSc</degrees>
<xref ref-type="aff" rid="yoi180103aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McGrath</surname>
<given-names>John J.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="yoi180103aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Suppli</surname>
<given-names>Nis P.</given-names>
</name>
<degrees>MD</degrees>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="yoi180103aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hougaard</surname>
<given-names>David M.</given-names>
</name>
<degrees>DrMedSc</degrees>
<xref ref-type="aff" rid="yoi180103aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bybjerg-Grauholm</surname>
<given-names>Jonas</given-names>
</name>
<degrees>MSE</degrees>
<xref ref-type="aff" rid="yoi180103aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bækvad-Hansen</surname>
<given-names>Marie</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="yoi180103aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Andreassen</surname>
<given-names>Ole</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="yoi180103aff8">
<sup>8</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff9">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pedersen</surname>
<given-names>Carsten B.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="yoi180103aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pedersen</surname>
<given-names>Marianne G.</given-names>
</name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="yoi180103aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mors</surname>
<given-names>Ole</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="yoi180103aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff10">
<sup>10</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nordentoft</surname>
<given-names>Merete</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="yoi180103aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Børglum</surname>
<given-names>Anders D.</given-names>
</name>
<degrees>MD</degrees>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="yoi180103aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff11">
<sup>11</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Werge</surname>
<given-names>Thomas</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="yoi180103aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff12">
<sup>12</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff13">
<sup>13</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Agerbo</surname>
<given-names>Esben</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="yoi180103aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="yoi180103aff3">
<sup>3</sup>
</xref>
</contrib>
<on-behalf-of>for the Bipolar Disorder Working Group of the Psychiatric Genomics Consortium</on-behalf-of>
</contrib-group>
<aff id="yoi180103aff1"><label>1</label>iPSYCH, The Lundbeck Foundation Initiative for Integrated Psychiatric Research, Denmark</aff>
<aff id="yoi180103aff2"><label>2</label>National Centre for Register-based Research, Department of Economics and Business Economics, Aarhus University, Aarhus, Denmark</aff>
<aff id="yoi180103aff3"><label>3</label>Center for Integrated Register-based Research at Aarhus University, Aarhus, Denmark</aff>
<aff id="yoi180103aff4"><label>4</label>Queensland Brain Institute, The University of Queensland, St Lucia, Queensland, Australia</aff>
<aff id="yoi180103aff5"><label>5</label>Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, Queensland, Australia</aff>
<aff id="yoi180103aff6"><label>6</label>Mental Health Centre Copenhagen, Capital Region of Denmark, Copenhagen University Hospital, Copenhagen, Denmark</aff>
<aff id="yoi180103aff7"><label>7</label>Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark</aff>
<aff id="yoi180103aff8"><label>8</label>The Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, University of Oslo, Oslo, Norway</aff>
<aff id="yoi180103aff9"><label>9</label>Oslo University Hospital, Oslo, Norway</aff>
<aff id="yoi180103aff10"><label>10</label>Psychosis Research Unit, Aarhus University Hospital, Risskov, Denmark</aff>
<aff id="yoi180103aff11"><label>11</label>Centre for Integrative Sequencing, Department of Biomedicine and iSEQ, Aarhus University, Aarhus, Denmark</aff>
<aff id="yoi180103aff12"><label>12</label>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark</aff>
<aff id="yoi180103aff13"><label>13</label>Institute of Biological Psychiatry, Copenhagen Mental Health Services, Copenhagen, Denmark</aff>
<author-notes>
<title>Article Information</title>
<p content-type="byline-footnote" specific-use="print"><bold>Group Information:</bold> The members of the Bipolar Disorder Working Group of the Psychiatric Genomics Consortium are listed at the end of this article.</p>
<corresp id="yoi180103cor1"><bold>Corresponding Author:</bold> Katherine L. Musliner, PhD, Fuglesangs Alle 26, Building R, 8210 Aarhus V, Denmark (<email xlink:href="klm@econ.au.dk">klm@econ.au.dk</email>).</corresp>
<p><bold>Accepted for Publication:</bold> October 17, 2018.</p>
<p content-type="published-online"><bold>Published Online:</bold> January 30, 2019. doi:<uri content-type="doi">10.1001/jamapsychiatry.2018.4166</uri></p>
<p content-type="author-contributions"><bold>Author Contributions:</bold> Dr Musliner had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p>
<p><italic>Concept and design: </italic>Musliner, Hougaard, Borglum, Agerbo.</p>
<p><italic>Acquisition, analysis, or interpretation of data: </italic>Musliner, Bo Mortensen, McGrath, Suppli, Bybjerg-Grauholm, Baekvad-Hansen, Andreassen, C. Pedersen, M. Pedersen, Mors, Nordentoft, Borglum, Werge, Agerbo.</p>
<p><italic>Drafting of the manuscript: </italic>Musliner.</p>
<p><italic>Critical revision of the manuscript for important intellectual content: </italic>All authors.</p>
<p><italic>Statistical analysis: </italic>Musliner, Agerbo.</p>
<p><italic>Obtained funding: </italic>Bo Mortensen, Hougaard, Mors, Nordentoft, Borglum, Werge.</p>
<p><italic>Administrative, technical, or material support: </italic>Bybjerg-Grauholm, Baekvad-Hansen, Andreassen, C. Pedersen, Mors, Borglum, Werge, Agerbo.</p>
<p><italic>Supervision: </italic>Bo Mortensen, Suppli, Mors, Nordentoft, Borglum, Agerbo.</p>
<p content-type="study-group-members-end"><bold>Group Information:</bold> The Bipolar Disorder Working Group of the Psychiatric Genomics Consortium members are Eli A. Stahl, Icahn School of Medicine at Mount Sinai and Broad Institute; Gerome Breen, King’s College London; Andreas J. Forstner, University of Basel, University of Bonn, Institute of Medical Genetics and Pathology, and University Hospital Basel; Andrew McQuillin, University College London; Stephan Ripke, Stanley Center for Psychiatric Research, Broad Institute, Charité-Universitätsmedizin, and Massachusetts General Hospital; Vassily Trubetskoy, Charité-Universitätsmedizin; Manuel Mattheisen, Aarhus University, Karolinska Institutet, University Hospital Würzburg, and The Lundbeck Foundation Initiative for Integrative Psychiatric Research; Yunpeng Wang, Mental Health Centre Sct. Hans and University of Oslo; Jonathan R I Coleman, King’s College London; Héléna A. Gaspar, King’s College London; Christiaan A. de Leeuw, Universiteit Amsterdam; Stacy Steinberg, Amgen; Jennifer M. Whitehead Pavlides, The University of Queensland; Maciej Trzaskowski, University of Queensland; Tune H. Pers, Broad Institute and Boston Children’s Hospital; Peter A. Holmans, Cardiff University; Liam Abbott, Broad Institute; Esben Agerbo, The Lundbeck Foundation Initiative for Integrative Psychiatric Research and Aarhus University; Huda Akil, University of Michigan; Diego Albani, Istituto Di Ricerche Farmacologiche Mario Negri; Ney Alliey-Rodriguez, University of Chicago; Thomas D. Als, Aarhus University and the Lundbeck Foundation Initiative for Integrative Psychiatric Research; Adebayo Anjorin, Berkshire Healthcare NHS Foundation Trust; Verneri Antilla, Massachusetts General Hospital; Swapnil Awasthi, Charité-Universitätsmedizin; Judith A. Badner, Rush University Medical Center; Marie Bækvad-Hansen, the Lundbeck Foundation Initiative for Integrative Psychiatric Research and Statens Serum Institut; Jack D. Barchas, Weill Cornell Medical College; Nicholas Bass, University College London; Michael Bauer, University Hospital Carl Gustav Carus; Richard Belliveau, Broad Institute; Sarah E. Bergen, Karolinska Institutet; Carsten Bøcker Pedersen, the Lundbeck Foundation Initiative for Integrative Psychiatric Research and Aarhus University; Erlend Bøen, Diakonhjemmet Hospital; Marco Boks, UMC Utrecht Hersencentrum Rudolf Magnus; James Boocock, University of California Los Angeles; Monika Budde, University Hospital, LMU Munich; William Bunney, University of California, Irvine; Margit Burmeister, University of Michigan; Jonas Bybjerg-Grauholm, the Lundbeck Foundation Initiative for Integrative Psychiatric Research and Statens Serum Institut; William Byerley, University of California San Francisco; Miquel Casas, Instituto de Salud Carlos III, Biomedical Network Research Centre on Mental Health, Hospital Universitari Vall d´Hebron, Universitat Autònoma de Barcelona, and Universitat Autònoma de Barcelona; Felecia Cerrato, Broad Institute; Pablo Cervantes, McGill University Health Center; Kimberly Chambert, Broad Institute; Alexander W. Charney, Icahn School of Medicine at Mount Sinai; Danfeng Chen, Broad Institute; Claire Churchhouse, Broad Institute and Massachusetts General Hospital; Toni-Kim Clarke, University of Edinburgh; William Coryell, University of Iowa Hospitals and Clinics; David W. Craig, USC; Cristiana Cruceanu, McGill University Health Center and Max Planck Institute of Psychiatry; David Curtis, Queen Mary University of London and University College London; Piotr M. Czerski, Poznan University of Medical Sciences; Anders M. Dale, University of California San Diego; Simone de Jong, King’s College London; Franziska Degenhardt, University of Bonn; Jurgen Del-Favero, University of Antwerp; J. Raymond DePaulo, Johns Hopkins University School of Medicine; Srdjan Djurovic, Oslo University Hospital Ullevål and University of Bergen; Amanda L. Dobbyn, Icahn School of Medicine at Mount Sinai; Ashley Dumont, Broad Institute; Torbjørn Elvsåshagen, Oslo University Hospital; Valentina Escott-Price, Cardiff University; Chun Chieh Fan, University of California San Diego; Sascha B Fischer, University of Basel and University Hospital Basel; Matthew Flickinger, University of Michigan; Tatiana M. Foroud, Indiana University; Liz Forty, Cardiff University; Josef Frank, Heidelberg University; Christine Fraser, Cardiff University; Nelson B. Freimer, University of California Los Angeles; Louise Frisén, Karolinska University Hospital; Katrin Gade, University Hospital, LMU Munich and University Medical Center Göttingen; Diane Gage, Broad Institute; Julie Garnham, Dalhousie University; Claudia Giambartolomei, University of California Los Angeles; Marianne Giørtz Pedersen, the Lundbeck Foundation Initiative for Integrative Psychiatric Research and Aarhus University; Jaqueline Goldstein, Broad Institute; Scott D. Gordon, QIMR Berghofer Medical Research Institute; Katherine Gordon-Smith, University of Worcester; Elaine K Green, Plymouth University Peninsula Schools of Medicine and Dentistry; Melissa J. Green, University of New South Wales; Tiffany A. Greenwood, University of California San Diego; Jakob Grove, Aarhus University and the Lundbeck Foundation Initiative for Integrative Psychiatric Research; Weihua Guan, University of Minnesota System; José Guzman Parra, University Regional Hospital, Biomedicine Institute, IBIMA; Marian L Hamshere, Cardiff University; Martin Hautzinger, Eberhard Karls Universität Tübingen; Urs Heilbronner, University Hospital, LMU Munich; Stefan Herms, University of Basel, University of Bonn, and University Hospital Basel; Maria Hipolito, Howard University Hospital; Per Hoffmann, University of Basel, University of Bonn, and University Hospital Basel; Dominic Holland, University of California San Diego, La Jolla; Laura Huckins, Icahn School of Medicine at Mount Sinai; Stéphane Jamain, Université Paris Est; Jessica S. Johnson, Icahn School of Medicine at Mount Sinai; Anders Juréus, Karolinska Institutet; Radhika Kandaswamy, King’s College London; Robert Karlsson, Karolinska Institutet; James L. Kennedy, Campbell Family Mental Health Research Institute and University of Toronto; Sarah Kittel-Schneider, University Hospital Frankfurt; Sarah V. Knott, (University of Worcester; James A. Knowles, SUNY Downstate Medical Center College of Medicine; Manolis Kogevinas, Center for Research in Environmental Epidemiology, Barcelona; Anna C. Koller, University of Bonn; Ralph Kupka, VU medisch centrum, Amsterdam; Catharina Lavebratt, Karolinska University Hospital; Jacob Lawrence, North East London NHS Foundation Trust; William B. Lawson, Howard University Hospital; Markus Leber, University Hospital Cologne; Phil H Lee, Broad Institute and Massachusetts General Hospital; Shawn E. Levy, HudsonAlpha Institute for Biotechnology; Jun Z. Li, University of Michigan; Chunyu Liu, University of Illinois at Chicago College of Medicine; Susanne Lucae, Max Planck Institute of Psychiatry; Anna Maaser, University of Bonn; Donald J. MacIntyre, Mental Health, NHS 24, Glasgow and University of Edinburgh; Pamela B. Mahon, Johns Hopkins University School of Medicine and Brigham and Women’s Hospital; Wolfgang Maier, University of Bonn; Lina Martinsson, Karolinska University Hospital; Steve McCarroll, Broad Institute and Harvard Medical School; Peter McGuffin, King’s College London; Melvin G. McInnis, University of Michigan; James D. McKay, International Agency for Research on Cancer; Helena Medeiros, SUNY Downstate Medical Center College of Medicine; Sarah E. Medland, QIMR Berghofer Medical Research Institute; Fan Meng, University of Michigan; Lili Milani, University of Tartu; Grant W. Montgomery, University of Queensland; Derek W. Morris, National University of Ireland and Trinity College Dublin; Thomas W. Mühleisen, University of Basel and Research Centre Jülich; Niamh Mullins, King’s College London; Hoang Nguyen, Icahn School of Medicine at Mount Sinai; Caroline M. Nievergelt, University of California San Diego, La Jolla and Veterans Affairs San Diego Healthcare System; Annelie Nordin Adolfsson, Umeå University; Evaristus A. Nwulia, Howard University Hospital; Claire O'Donovan, Dalhousie University; Loes M. Olde Loohuis, University of California Los Angeles; Anil P. S. Ori, University of California Los Angeles; Lilijana Oruc, Clinical Center University of Sarajevo; Urban Ösby, Karolinska University Hospital; Roy H. Perlis, Harvard Medical School and Massachusetts General Hospital; Amy Perry, University of Worcester; Andrea Pfennig, Technische Universität Dresden; James B. Potash, Johns Hopkins University School of Medicine; Shaun M. Purcell, Icahn School of Medicine at Mount Sinai and Brigham and Women’s Hospital; Eline J. Regeer, Outpatient Clinic for Bipolar Disorder; Andreas Reif, University Hospital Frankfurt; Céline S. Reinbold, University of Basel and University Hospital Basel; John P. Rice, (Washington University in Saint Louis; Fabio Rivas, University Regional Hospital, Biomedicine Institute, Málaga; Margarita Rivera, King’s College London and University of Granada; Panos Roussos, Icahn School of Medicine at Mount Sinai; Douglas M. Ruderfer, Vanderbilt University Medical Center; Euijung Ryu, Mayo Clinic, Rochester; Cristina Sánchez-Mora, Biomedical Network Research Centre on Mental Health, Madrid, Hospital Universitari Vall d´Hebron, and Universitat Autònoma de Barcelona; Alan F. Schatzberg, Stanford University School of Medicine; William A. Scheftner, Rush University Medical Center; Nicholas J. Schork, Scripps Translational Science Institute; Cynthia Shannon Weickert, University of New South Wales and Neuroscience Research Australia; Tatyana Shehktman, University of California San Diego, La Jolla; Paul D. Shilling, University of California San Diego, La Jolla; Engilbert Sigurdsson, University of Iceland; Claire Slaney, Dalhousie University; Olav B. Smeland, University of California San Diego, La Jolla, Oslo University Hospital, and University of Oslo; Janet L. Sobell, University of Southern California, Los Angeles; Christine Søholm Hansen, the Lundbeck Foundation Initiative for Integrative Psychiatric Research and Statens Serum Institut; Anne T. Spijker, Mood Disorders, PsyQ; David St Clair, University of Aberdeen; Michael Steffens, Federal Institute for Drugs and Medical Devices; John S. Strauss, University of Toronto and Centre for Addiction and Mental Health; Fabian Streit, Heidelberg University; Jana Strohmaier, Heidelberg University; Szabolcs Szelinger, TGen; Robert C. Thompson, University of Michigan; Thorgeir E. Thorgeirsson, deCODE Genetics/Amgen; Jens Treutlein, Heidelberg University; Helmut Vedder, Psychiatrisches Zentrum Nordbaden; Weiqing Wang, Icahn School of Medicine at Mount Sinai; Stanley J. Watson, University of Michigan; Thomas W. Weickert, University of New South Wales and Neuroscience Research Australia; Stephanie H. Witt, Heidelberg University; Simon Xi, Pfizer Global Research and Development; Wei Xu, Princess Margaret Cancer Centre and University of Toronto; Allan H. Young, King’s College London; Peter Zandi, Johns Hopkins University Bloomberg School of Public Health; Peng Zhang, Johns Hopkins University School of Medicine; Sebastian Zollner, University of Michigan; Rolf Adolfsson, Umeå University; Ingrid Agartz, Karolinska Institutet, Diakonhjemmet Hospital, and University of Oslo; Martin Alda, Dalhousie University; Lena Backlund, Karolinska University Hospital; Bernhard T. Baune, University of Adelaide; Frank Bellivier, Assistance Publique-Hôpitaux de Paris, FondaMental Foundation, INSERM, and Université Paris Diderot; Wade H. Berrettini, University of Pennsylvania; Joanna M. Biernacka, Mayo Clinic; Douglas H. R. Blackwood, University of Edinburgh; Michael Boehnke, University of Michigan; Anders D. Børglum, Aarhus University and the Lundbeck Foundation Initiative for Integrative Psychiatric Research; Aiden Corvin, Trinity College Dublin; Nicholas Craddock, Cardiff University; Mark J. Daly, Broad Institute and Massachusetts General Hospital; Udo Dannlowski, University of Münster; Tõnu Esko, Broad Institute, Harvard Medical School, University of Tartu, and Children’s Hospital Boston; Bruno Etain, Assistance Publique-Hôpitaux de Paris, INSERM, Université Paris Diderot, and the Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, London; Mark Frye, Mayo Clinic; Janice M. Fullerton, Neuroscience Research Australia and University of New South Wales; Elliot S. Gershon, University of Chicago; Michael Gill, Trinity College Dublin; Fernando Goes, Johns Hopkins University School of Medicine; Maria Grigoroiu-Serbanescu, Alexandru Obregia Clinical Psychiatric Hospital; Joanna Hauser, Poznan University of Medical Sciences; David M. Hougaard, the Lundbeck Foundation Initiative for Integrative Psychiatric Research and Statens Serum Institut; Christina M. Hultman, Karolinska Institutet; Ian Jones, Cardiff University; Lisa A. Jones, University of Worcester; René S. Kahn, Icahn School of Medicine at Mount Sinai and UMC Utrecht Hersencentrum Rudolf Magnus; George Kirov, Cardiff University; Mikael Landén, Karolinska Institutet and University of Gothenburg; Marion Leboyer, Université Paris Est, Assistance Publique-Hôpitaux, and INSERM; Cathryn M. Lewis, King’s College London; Qingqin S. Li, Janssen Research and Development, LLC; Jolanta Lissowska, M. Sklodowska-Curie Cancer Center and Institute of Oncology; Nicholas G. Martin, QIMR Berghofer Medical Research Institute and the University of Queensland; Fermin Mayoral, University Regional Hospital, Biomedicine Institute, Málaga; Susan L. McElroy, Lindner Center of HOPE; Andrew M. McIntosh, University of Edinburgh; Francis J. McMahon, National Institute of Mental Health; Ingrid Melle, Oslo University Hospital and University of Oslo; Andres Metspalu, University of Tartu; Philip B. Mitchell, University of New South Wales; Gunnar Morken, Norwegian University of Science and Technology and St Olavs University Hospital; Ole Mors, the Lundbeck Foundation Initiative for Integrative Psychiatric Research and Aarhus University Hospital; Preben Bo Mortensen, Aarhus University and the Lundbeck Foundation Initiative for Integrative Psychiatric Research; Bertram Müller-Myhsok, Max Planck Institute of Psychiatry and University of Liverpool; Richard M. Myers, HudsonAlpha Institute for Biotechnology; Benjamin M. Neale, Broad Institute and Massachusetts General Hospital; Vishwajit Nimgaonkar, University of Pittsburgh; Merete Nordentoft, the Lundbeck Foundation Initiative for Integrative Psychiatric Research and University of Copenhagen; Markus M. Nöthen, University of Bonn; Michael C. O'Donovan, Cardiff University; Ketil J. Oedegaard, University of Bergen; Michael J. Owen, Cardiff University; Sara A. Paciga, Pfizer Global Research and Development; Carlos Pato, SUNY Downstate Medical Center College of Medicine; Michele T. Pato, SUNY Downstate Medical Center College of Medicine; Danielle Posthuma, Vrije Universiteit Amsterdam; Josep Antoni Ramos-Quiroga, Biomedical Network Research Centre on Mental Health, Madrid, Hospital Universitari Vall d´Hebron, Universitat Autònoma de Barcelona, and Universitat Autònoma de Barcelona; Marta Ribasés, Biomedical Network Research Centre on Mental Health, Madrid, Hospital Universitari Vall d´Hebron, and Universitat Autònoma de Barcelona; Marcella Rietschel, Heidelberg University; Guy A. Rouleau, McGill University and Montreal Neurological Institute and Hospital; Martin Schalling, Karolinska University Hospital; Peter R. Schofield, Neuroscience Research Australia and University of New South Wales; Thomas G. Schulze, University Hospital, LMU Munich, Johns Hopkins University School of Medicine, Heidelberg University, University Medical Center Göttingen, and the National Institute of Mental Health; Alessandro Serretti, University of Bologna; Jordan W. Smoller, Broad Institute and Massachusetts General Hospital; Hreinn Stefansson, deCODE Genetics/Amgen; Kari Stefansson, deCODE Genetics/Amgen and University of Iceland; Eystein Stordal, Hospital Namsos, and Norges Teknisk Naturvitenskapelige Universitet Fakultet for naturvitenskap og teknologi; Patrick F. Sullivan, Karolinska Institutet and University of North Carolina at Chapel Hill; Gustavo Turecki, McGill University; Arne E. Vaaler, Sankt Olavs Hospital Universitetssykehuset i Trondheim; Eduard Vieta, University of Barcelona; John B. Vincent, Centre for Addiction and Mental Health, Toronto; Thomas Werge, the Lundbeck Foundation Initiative for Integrative Psychiatric Research and University of Copenhagen; John I. Nurnberger, Indiana University School of Medicine; Naomi R. Wray, the University of Queensland; Arianna Di Florio, Cardiff University and University of North Carolina at Chapel Hill; Howard J. Edenberg, Indiana University School of Medicine; Sven Cichon, University of Basel, University of Bonn, University Hospital Basel, and Research Centre Jülich; Roel A. Ophoff, UMC Utrecht Hersencentrum Rudolf Magnus and University of California Los Angeles; Laura J. Scott, University of Michigan; Ole A. Andreassen, Oslo University Hospital and University of Oslo; John Kelsoe, University of California San Diego; and Pamela Sklar, Icahn School of Medicine.</p>
<p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Andreassen reports receiving personal fees and speaker’s honorarium from Lundbeck. No other disclosures were reported.</p>
<p content-type="funding-statement"><bold>Funding/Support:</bold> This study was funded by the Lundbeck Foundation (grant R155-2014-1724). The Psychiatric Genomics Consortium (PGC) has received major funding from the US National Institute of Mental Health and the US National Institute of Drug Abuse (grants U01 MH109528 and U01 MH1095320).</p>
<p><bold>Role of the Funder/Sponsor:</bold> The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p>
<p><bold>Additional Contributions:</bold> We thank the Broad Institute for genotyping and the PGC Major Depression and Schizophrenia Work Groups as well as 23andMe for making summary statistics available. We thank the Bipolar Disorders Working Group of the PGC for making leave one out summary statistics available in advance of publication. We also thank Thomas Damm Als, PhD, Aarhus University, for generating the principal component variables and Jakob Grove, PhD, Aarhus University, for generating the polygenic risk scores.</p>
</author-notes>
<pub-date iso-8601-date="2019-01-30T10:00" pub-type="epub">
<day>30</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>30</day>
<month>1</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="epub"/>. -->
<volume>76</volume>
<issue>5</issue>
<fpage>516</fpage>
<lpage>525</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="final">
<day>7</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright 2019 American Medical Association. All Rights Reserved.</copyright-statement>
</permissions>
<self-uri content-type="pdf-version" xlink:href="jamapsychiatry-76-516.pdf">jamapsychiatry-76-516.pdf</self-uri>
<self-uri content-type="silverchair" xlink:href="https://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/jamapsychiatry.2018.4166"></self-uri>
<related-article ext-link-type="doi" id="d35e458" related-article-type="commentary" xlink:href="10.1001/jamapsychiatry.2018.3975"></related-article>
<abstract abstract-type="key-points">
<title>Key Points</title>
<sec id="ab-yoi180103-1">
<title>Question</title>
<p>Are polygenic liabilities for major depression, bipolar disorder, and schizophrenia associated with depression in the general population?</p>
</sec>
<sec id="ab-yoi180103-2">
<title>Findings</title>
<p>In this case-cohort study of 34 573 individuals, each 1 SD increase in the polygenic risk for major depression was associated with a 30% increase in the hazard for a depression diagnosis in hospital-based psychiatric care. Polygenic liabilities for schizophrenia and bipolar disorder were also associated with an increased hazard of depression but to a lesser extent.</p>
</sec>
<sec id="ab-yoi180103-3">
<title>Meaning</title>
<p>Polygenic risk scores trained in samples of prevalent major depression cases are associated with first depression in the general population.</p>
</sec>
</abstract>
<abstract>
<sec id="ab-yoi180103-4">
<title>Importance</title>
<p>Although the usefulness of polygenic risk scores as a measure of genetic liability for major depression (MD) has been established, their association with depression in the general population remains relatively unexplored.</p>
</sec>
<sec id="ab-yoi180103-5">
<title>Objective</title>
<p>To evaluate whether polygenic risk scores for MD, bipolar disorder (BD), and schizophrenia (SZ) are associated with depression in the general population and explore whether these polygenic liabilities are associated with heterogeneity in terms of age at onset and severity at the initial depression diagnosis.</p>
</sec>
<sec id="ab-yoi180103-6">
<title>Design, Setting, and Participants</title>
<p>Participants were drawn from the Danish iPSYCH2012 case-cohort study, a representative sample drawn from the population of Denmark born between May 1, 1981, and December 31, 2005. The hazard of depression was estimated using Cox regressions modified to accommodate the case-cohort design. Case-only analyses were conducted using linear and multinomial regressions. The data analysis was conducted from February 2017 to June 2018.</p>
</sec>
<sec id="ab-yoi180103-7">
<title>Exposures</title>
<p>Polygenic risk scores for MD, BD, and SZ trained using the most recent genome-wide association study results from the Psychiatric Genomics Consortium.</p>
</sec>
<sec id="ab-yoi180103-8">
<title>Main Outcomes and Measures</title>
<p>The main outcome was first depressive episode (<italic>International Statistical Classification of Diseases and Related Health Problems, Tenth Revision </italic>[<italic>ICD-10</italic>] code F32) treated in hospital-based psychiatric care. Severity at the initial diagnosis was measured using the <italic>ICD-10</italic> code severity specifications (mild, moderate, severe without psychosis, and severe with psychosis) and treatment setting (inpatient, outpatient, and emergency).</p>
</sec>
<sec id="ab-yoi180103-9">
<title>Results</title>
<p>Of 34 573 participants aged 10 to 31 years at censoring, 68% of those with depression were female compared with 48.9% of participants without depression. Each SD increase in polygenic liability for MD, BD, and SZ was associated with 30% (hazard ratio [HR], 1.30; 95% CI, 1.27-1.33), 5% (HR, 1.05; 95% CI, 1.02-1.07), and 12% (HR, 1.12; 95% CI, 1.09-1.15) increases in the hazard of depression, respectively. Among cases, a higher polygenic liability for BD was associated with earlier depression onset (β = −.07; SE = .02; <italic>P</italic> = .002).</p>
</sec>
<sec id="ab-yoi180103-10">
<title>Conclusions and Relevance</title>
<p>Polygenic liability for MD is associated with first depression in the general population, which supports the idea that these scores tap into an underlying liability for developing the disorder. The fact that polygenic risk for BD and polygenic risk for SZ also were associated with depression is consistent with prior evidence that these disorders share some common genetic overlap. Variations in polygenic liability may contribute slightly to heterogeneity in clinical presentation, but these associations appear minimal.</p>
</sec>
</abstract>
<abstract abstract-type="teaser">
<p>This cohort study explores the association of polygenic risk scores for major depression, bipolar disorder, and schizophrenia with the risk for depression in the Danish population.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>